In focus · trending topic

IN-TRANSIT MELANOMA

2 stories · following the connections

PROVECTUS BIOPHARMACEUTICALS ANNOUNCES CHANGES TO BOARD OF DIRECTORS

By Nasdaq OMXApr 24, 2018, 11:00 AM UTC

SECOND STUDY OF EXPANDED ACCESS PATIENTS TREATED WITH PV-10 FOR IN-TRANSIT MELANOMA PUBLISHED IN JOURNAL OF SURGICAL ONCOLOGY

By Nasdaq OMXApr 19, 2018, 10:00 AM UTC